Immunovant, INC. (IMVT) SEC Filings — 2025
16 SEC filings for Immunovant, INC. (IMVT) in 2025.
Filings
- Immunovant, INC. 8-K Filing — 8-K · Dec 12, 2025
- Immunovant Files 8-K: Unspecified Event Reported — 8-K · Dec 11, 2025
- Immunovant Reports Leadership and Compensation Changes — 8-K · Nov 21, 2025
- Immunovant Files 8-K on Financials — 8-K · Nov 10, 2025
- Immunovant Files 8-K — 8-K · Sep 3, 2025
- Immunovant Files 8-K on Shareholder Vote Matters — 8-K · Aug 28, 2025
- Immunovant Q1: No Revenue, Focus on Pipeline Development — 10-Q · Aug 11, 2025
- Immunovant Appoints New Director and CMO — 8-K · Jul 29, 2025
- Immunovant Sets August 27 Virtual Annual Meeting, Details Equity Awards — DEF 14A · Jul 9, 2025
- Immunovant's Net Loss Widens to $304M Amid R&D Push — 10-K · May 29, 2025
- Immunovant Announces Board Changes and New CLO — 8-K · Apr 21, 2025
- Immunovant Files 8-K: Regulatory, Other Events & Exhibits — 8-K · Mar 19, 2025
- Immunovant Files 10-Q for Q3 FY2025 — 10-Q · Feb 6, 2025
- Immunovant, Inc. Files 8-K — 8-K · Jan 24, 2025
- Immunovant Files 8-K for Regulatory Disclosure — 8-K · Jan 14, 2025
- Immunovant Files 8-K: Material Agreements & Equity Sales — 8-K · Jan 13, 2025